Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
1,265 results
- EMTIndependent statistical analysis of Enhanced Community-Based Asthma Monitoring Through Novel Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824936).
- Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05282459).
- ENCOREIndependent statistical analysis of Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENCORE-VTIndependent statistical analysis of Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583050).
- ENDURANCE-2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection: primary endpoint results, effect estimate with confidence…
- ENESTPathIndependent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.: primary endpoint results, effect estimate…
- ENVISIONIndependent statistical analysis of A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Enzastaurin for Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Enzastaurin for Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00192114).
- Epidemiology of Depression, Anxiety, and Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology of Depression, Anxiety, and Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717041).
- EPMCS-CAIndependent statistical analysis of A Prospective, Multi-Center Evaluation of the ECHELON CIRCULAR Powered Stapler in Left-Sided Colorectal Anastomoses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970502).
- Estrogen for Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Estrogen for Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01083641).
- ET-01 in Subjects With Lateral Canthal Lines: Complete Statistical AnalysisIndependent statistical analysis of ET-01 in Subjects With Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03326856).
- Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01230177).
- Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Etoposide in Patients With COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Etoposide in Patients With COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04356690).
- Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: Complete Statistical AnalysisIndependent statistical analysis of Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EV ICDIndependent statistical analysis of Extravascular ICD Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04060680).
- Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating Online Messages About Colon Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Online Messages About Colon Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06134089).
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: primary endpoint results, effect estimate with confidence interval, sample-size…
- Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: primary endpoint results, effect…
- Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of a Systematic Approach to Weaning From Mechanical Ventilation: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Systematic Approach to Weaning From Mechanical Ventilation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01482429).
- Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of Reactogenicity and Safety of GSK Biologicals’ Rotarix™ (Human Rotavirus Vaccine) in Infants: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05019742).
- Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation: primary endpoint results, effect estimate with confidence interval,…
- Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).
- Everolimus for Cancer With TSC1 or TSC2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Cancer With TSC1 or TSC2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201212).